Multiple Endocrine Neoplasia type 1
GPTKB entity
Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:adrenal_cortical_carcinoma
gptkb:adrenal_cancer |
| gptkbp:affects |
endocrine glands
|
| gptkbp:associated_with |
hyperparathyroidism
pituitary tumors pancreatic endocrine tumors |
| gptkbp:caused_by |
mutation in the ME N1 gene
|
| gptkbp:complications |
gptkb:Company
osteoporosis malignancy |
| gptkbp:current_use |
gptkb:neurofibromatosis_type_1
Multiple Endocrine Neoplasia type 2 |
| gptkbp:descendant |
autosomal dominant
|
| gptkbp:first_described_by |
in the 1950s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Multiple Endocrine Neoplasia type 1
|
| gptkbp:is_popular_in |
rare
|
| gptkbp:research_focus |
gptkb:physicist
new treatment options understanding genetic mechanisms |
| gptkbp:risk_factor |
family history
genetic predisposition |
| gptkbp:screenings |
imaging studies for tumors
regular monitoring of hormone levels |
| gptkbp:social_responsibility |
variable
genetic testing |
| gptkbp:symptoms |
gptkb:historical_event
anxiety fatigue nausea sleep disturbances weight loss abdominal pain vomiting muscle weakness headaches numbness bone pain tingling sensations changes in appetite sexual dysfunction mood changes kidney stones skin changes gastrointestinal issues vision changes sweating abnormalities irregular menstrual cycles excessive thirst excessive urination |
| gptkbp:treatment |
gptkb:hospital
hormone replacement therapy medication for symptoms |